靶向 ICAM1 的共刺激通过与 TCR 信号协同将 HER2 CAR-T 细胞毒性扩展至 HER2 低表达和 HER2 阴性肿瘤
ICAM1-targeted costimulation extends HER2 CAR T cytotoxicity to HER2-low and HER2-negative tumors through synergy with TCR signaling.
肿瘤细胞治疗研究
ALL SOURCES
把在研试验和前沿论文合在一起看,按时间倒序排列。本页条数 = 前沿论文 + 临床试验两块之和(导航里的「临床试验」板块只收在招的那部分,不另计入)。
ICAM1-targeted costimulation extends HER2 CAR T cytotoxicity to HER2-low and HER2-negative tumors through synergy with TCR signaling.
Brave new world-new and emerging treatments for gastric cancer.
Recent advances in immune-based approaches for the treatment of esophagogastric cancer.
免疫治疗,特别是免疫检查点抑制剂(ICI)类药物类别的引入,近年来改变了许多癌症的治疗范式。抗 PD-1 疗法现已成为局部和晚期疾病患者的新标准治疗。
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。